Evaluating the Pink and Pearl Campaign for Lung Cancer Screening
Evaluating the Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
This study is testing if the Pink and Pearl Campaign can encourage women aged 50-80 getting mammograms to also get screened for lung cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 279 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Washington University School of Medicine Academic / other |
| Locations | 1 site (Creve Coeur, Missouri) |
| Trial ID | NCT06898333 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the effectiveness of the Pink and Pearl Campaign in promoting lung cancer screening among women aged 50-80 who are undergoing mammography at BJC West County. It utilizes a mixed methods approach, combining quantitative and qualitative data to evaluate the prevalence of lung cancer screening and the impact of the campaign on referrals and completion rates. The study also examines individual and environmental factors that influence screening behavior, grounded in the Integrated Screening Action Model.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 50-80 with a significant smoking history who are currently undergoing screening mammography.
Not a fit: Patients with a serious health problem that limits life expectancy or those who have been diagnosed with lung cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly increase lung cancer screening rates among eligible women, leading to earlier detection and improved outcomes.
How similar studies have performed: Other studies have shown success in using targeted campaigns to improve cancer screening rates, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria for Participants: * Undergoing screening mammography * Between the ages of 50-80 years (inclusive) * Reporting a 20 pack-year equivalent of either current smoking history or have quit in the past 15 years * Can speak and understand English * Ability to understand willingness to provide informed consent. Exclusion Criteria for Participants: * Diagnosed with a serious health problem that will likely limit life expectancy (such as previous history of lung cancer, symptoms of lung cancer such as hemoptysis or unexplained weight loss of more than 6.8 kg (15 lb) in the previous year) * Subjects with symptoms of lung cancer should get a diagnostic CT scan * Unable or unwilling to get treatment if lung cancer is found Eligibility Criteria for Providers: * Older than 20 years of age
Where this trial is running
Creve Coeur, Missouri
- Barnes-Jewish Hospital West County — Creve Coeur, Missouri, United States (Recruiting)
Study contacts
- Principal investigator: Beryne Odeny, M.D., MPH, Ph.D. — Washington University School of Medicine
- Study coordinator: Beryne Odeny, M.D., MPH, Ph.D.
- Email: beryne@wustl.edu
- Phone: 314-362-1183
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.